Most women suffer from vaginitis at least once in their lifetime; therefore, it is the most common cause for tens of millions of clinic visits each year.

Unfortunately, 40%- 50% of first clinic visits end with misdiagnosis, followed by wrong treatment, health complications, patient’s continuous suffering, repeated visits and huge redundant expenses.

​

Driven by the belief that women’s diagnosis should be faster, more accurate, and accessible to all, we developed Gyni  , a platform that redefines the diagnosis of vaginitis.

Following a successful clinical trial we started commercializing Gyni in Europe.